Loading in 2 Seconds...
Loading in 2 Seconds...
The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used by anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are very strong and cost less, with minimum damage to the ozone layer.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Sevoflurane, Isoflurane and Desflurane Market Share, Size,
Analysis, Growth, Trends and Forecasts to 2022 | Hexa Research
“The Sevoflurane, Isoflurane and Desflurane Market is
expected to reach USD 1.5 billion by 2022 in comparison to
USD 1.2 billion in 2014.”
The Sevoflurane, Isoflurane and Desflurane Market is expected to reach USD 1.5 billion by 2022 in comparison
to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used by
anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are very strong
and cost less, with minimum damage to the ozone layer.
One of the primary factors, triggering expansion in the sevoflurane, isoflurane and desflurane market includes
cardiovascular and respiratory diseases affecting the geriatric population. Rising cancer, orthopedic, spinal and
gastro-intestinal cases have also furthered the market. Cataract surgery is a major contributor to the global
market and will need a higher production of these chemicals.
Growing accidents and emergency cases also add income to the inhalation anesthesia market. Universal
insurance coverage as well as constant improvements in medical infrastructure also ensure the development of
the sevoflurane, isoflurane and desflurane market. These agents are administered to patients prior surgery,
making the induction of general anesthesia much simpler.
A major factor hindering the market is the quantity of CO2 released in the environment, leading to global
warming. Actually, only about 5 percent of the gases are consumed by patients. The rest are released into the
atmosphere and make it unhealthy. The most practical solution for this problem is the anesthetic recycling of
products used during the administration of general anesthesia.
Browse Details of Report@
Sevoflurane is one of the most commonly used volatile anesthetic agents. It is administered to babies and
children. Sevoflurane is ideal for patients with asthma or sensitive air passages. But its side-effects include
delirium and agitation. It can be given quickly without the use of intravenous instruments.
Sevoflurane would capture over 70% of the worldwide sevoflurane, isoflurane and desflurane market by 2022.
The agent is expected to exceed USD 1 billion by the same year. It’s widely utilized for being low-priced and
possessing therapeutic benefits.
Isoflurane is a halogen ether utilized frequently by veterinarians. It is administered intravenously, relaxes the
muscles and reduces pain. Isoflurane has also been used for inducing sleepiness for long durations during
surgery. It is expected to register a CAGR of about 10% by 2022.
Desflurane is a halogen ether used in general anesthesia. Its effectiveness is one-fifth of isoflurane. Desflurane
cannot be administered orally and requires an electrically heated dispenser to distribute the vapor. It is mostly
administered to bariatric patients and in cases of surgeries lasting for short durations.
The United States has a large geriatric population. This has led the region of North America to occupy the
biggest share in the worldwide inhalation anesthesia market in 2014. Surgical ambulatory and inpatient
procedures are the driving factors of North America.
Asia Pacific will experience the fastest growth by 2022. This is owing to the rise of chronic diseases and need for
better health infrastructure in the region. Medical tourism combined with insurance coverage will play a huge
role in sustaining the growth of the sevoflurane, isoflurane and desflurane market.
The market is currently dominated by AbbVie and Baxter International. However, it can expect strong
competition from manufacturers like Lunan Pharmaceutical Group and Piramal Enterprises.
Piramal Enterprises currently has isoflurane and sevoflurane production underway. It will manufacture generic
desflurane by 2016. AbbVie has sevoflurane and isoflurane under production. Baxter International is the only
one that manufactures all the three products.
Anesthesia has some unhealthy effects. The recycling companies of Deltasorb Technologies and Anesthetic Gas
Reclamation reprocess anesthesia containers and gases from hospital vents. Rising investments by the
aforementioned players would also accelerate the sales of the sevoflurane, isoflurane and desflurane market.
Browse Related Category Market Reports@
Table of Content of Sevoflurane, Isoflurane and Desflurane Market
Executive Summary & Digital Transformation industry critical success factors
Digital Transformation Market drivers
Digital Transformation Market restraints
Digital Transformation Key Market Opportunities
Digital Transformation Porters Analysis
Digital Transformation - PESTEL Analysis
Digital Transformation - Company Market Share Analysis
Digital Transformation Application Outlook
Digital Transformation Regional Outlook
Digital Transformation Company profiles
Research scope & assumptions
List of data sources
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Felton Office Plaza
6265 Highway 9
Felton, California 95018
Website - http://www.hexaresearch.com/